Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

4-Oxo-2-phenylchroman-6-yl propionate.

ABSTRACT: In the structure of the title compound, C(18)H(16)O(4), both the S and R enanti-omers appear to occupy in a random way four symmetry-equivalent sites of the unit cell in an approximately 4:1/1:4 ratio. The chiral C atom of the pyrone ring together with the phenyl ring bonded to this atom are disordered over two positions, the occupancy factor of the major component being 0.809?(5). Adjacent molecules are linked by weak C-H?O hydrogen bonds.

SUBMITTER: Kostrzewa-Suslow E

PROVIDER: S-EPMC2979424 | biostudies-literature | 2010 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

4-Oxo-2-phenylchroman-6-yl propionate.

Kostrzewa-Susłow Edyta E Białońska Agata A Janeczko Tomasz T

Acta crystallographica. Section E, Structure reports online 20100522 Pt 6

In the structure of the title compound, C(18)H(16)O(4), both the S and R enanti-omers appear to occupy in a random way four symmetry-equivalent sites of the unit cell in an approximately 4:1/1:4 ratio. The chiral C atom of the pyrone ring together with the phenyl ring bonded to this atom are disordered over two positions, the occupancy factor of the major component being 0.809 (5). Adjacent molecules are linked by weak C-H⋯O hydrogen bonds. ...[more]

PMID: 21579480

Similar Datasets

2-Oxo-2H-chromen-4-yl propionate.

Project description:In the title compound, C12H10O4, the atoms of the 2-oxo-2H-chromene ring system and the non-H atoms of the 4-substituent all lie on a crystallographic mirror plane. The mol-ecular structure exhibits an intra-molecular C-H?O hydrogen bond, which generates an S(6) ring. In the crystal, mol-ecules form R 3 (2)(12) trimeric units via C-H?O inter-actions which propagate into layers parallel to the ac plane. These layers are linked by weak C-H?O inter-actions along the [010] direction, generating a three-dimensional network.

| S-EPMC3770394 | biostudies-other

Methyl 2-{[(3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl-idene)(thio-phen-2-yl)meth-yl]amino}-3-phenyl-propionate.

Project description:In the title compound, C(25)H(23)N(3)O(3)S, an intra-molecular N-H?O inter-action generates an S(6) ring, which stabilizes the enamine-keto form of the compound. This S(6) ring and the pyrazole ring are essentially coplanar, making a dihedral angle of 1.49?(6)°. The bond lengths within the S(6) ring of the mol-ecule lie between classical single- and double-bond lengths, indicating extensive conjugation. The structure exhibits a thienyl-ring flip disorder, with occupancy factors in the ratio 64.7?(3):35.3?(3).

| S-EPMC3213630 | biostudies-literature

3-(Benzimidazolium-2-yl)propionate dihydrate.

Project description:In the crystal struture of the title compound, C(10)H(10)N(2)O(2)·2H(2)O, the component species are linked to the water mol-ecules by N-H⋯O and O-H⋯O hydrogen bonds to form a three-dimensional network structure.

| S-EPMC2959715 | biostudies-literature

Methyl 3-(4-methoxy-benzo-yl)propionate.

Project description:The asymmetric unit of the title compound, C(12)H(14)O(3), contains two independent mol-ecules, in which the benzene rings are oriented at a dihedral angle of 72.08 (3)°. In the crystal structure, inter-molecular C-H⋯O hydrogen bonds link the mol-ecules into centrosymmetric dimers. There are also C-H⋯π contacts between aromatic CH groups and the benzene rings.

| S-EPMC2960146 | biostudies-literature

Methyl 3-[(3,5-dichloro-anilino)carbon-yl]propionate.

Project description:In the title compound, C(11)H(11)Cl(2)NO(3), the amide O atom and the carbonyl O atom of the ester segment are anti to each other and anti to the H atoms of the adjacent -CH(2) groups. In the crystal structure, mol-ecules are packed into centrosymmetric dimers through inter-molecular N-H⋯O hydrogen bonds. The dimers are linked into a layer structure extending parallel to (02) by C-H⋯O hydrogen bonds.

| S-EPMC2979985 | biostudies-literature

Dimeth-yl(2-oxo-2-phenyl-eth-yl)sulfanium bromide.

Project description:Single crystals of the title compound, C(10)H(13)OS(+)·Br(-), were obtained from ethyl acetate/ethyl ether after reaction of acetophenone with hydro-bromic acid and dimethyl-sulfoxide. The carbonyl group is almost coplanar with the neighbouring phenyl ring [O-C-C-C = 178.9?(2)°]. The sulfanium group shows a trigonal-pyramidal geometry at the S atom. The crystal structure is stabil-ized by C-H?Br hydrogen-bonding inter-actions. Weak ?-? inter-actions link adjacent phenyl rings [centroid-centroid distance = 3.946?(2)?Å].

| S-EPMC3011718 | biostudies-literature

Methyl 3-[(1-butyl-1H-indol-3-yl)carbonyl-amino]propionate.

Project description:In the title mol-ecule, C(17)H(22)N(2)O(3), the mean plane of the terminal (C=O)OMe fragment and the indole plane form a dihedral angle of 78.94 (3)°. Inter-molecular N-H⋯O hydrogen bonds link the mol-ecules into chains extended along the c axis. The crystal packing exhibits π-π inter-actions, indicated by the short distance of 3.472 (2) Å between the centroids of the five-membered heterocycles of neighbouring mol-ecules.

| S-EPMC2969888 | biostudies-literature

17-oxo-DHA displays additive anti-inflammatory effects with fluticasone propionate and inhibits the NLRP3 inflammasome.

Project description:Chronic obstructive pulmonary disease (COPD) is characterized by reduced lung function associated with increased local and systemic inflammatory markers, such as TNFα and IL-1β. Glucocorticoids are used to treat this chronic disease, however their efficacy is low and new drugs are very much required. 17-oxo-DHA is a cyclooxygenase-2-dependent, electrophilic, α,β-unsaturated keto-derivative of docosahexaenoic acid with anti-inflammatory properties. We evaluated the action of 17-oxo-DHA alone or in combination with the steroid fluticasone propionate (FP) in peripheral blood mononuclear cells (PBMCs) from COPD patients and healthy individuals exposed to lipopolysaccharide. We show that PBMCs from COPD patients released higher levels of TNFα and IL-1β compared to controls. 17-oxo-DHA displayed strong anti-inflammatory effects. The addition of 17-oxo-DHA in combination with FP showed enhanced anti-inflammatory effects through the modulation of transcriptional and post-transcriptional mechanisms. 17-oxo-DHA, but not FP, was able to suppress the release of mature IL-1β through inhibition of the NLRP3 inflammasome. Furthermore, 17-oxo-DHA inhibited inflammasome-dependent degradation of the glucocorticoid receptor (GR). Our findings suggest that 17-oxo-DHA in combination with FP or other steroids might achieve higher therapeutic efficacy than steroids alone. Combined treatment might be particularly relevant in those conditions where increased inflammasome activation may lead to GR degradation and steroid-unresponsive inflammation.

| S-EPMC5121625 | biostudies-literature

2-Oxo-2-(2-oxo-2H-chromen-3-yl)ethyl di-ethyl-dithio-carbamate.

Project description:In the title compound, C16H17NO3S2, the dihedral angles between the O/C/C/S group and the 2H-chromene ring system and the thio-carbamate group are 14.46?(9) and 83.30?(9)°, respectively. The bond-angle sum at the N atom is 360.0°. One of the methyl C atoms lies above the thio-carbamate plane and one lies below it [deviations = 1.264?(3) and -1.147?(3)?Å, respectively]. In the crystal, inversion dimers linked by pairs of C-H?O hydrogen bonds generate R 2 (2)(10) loops. Weak aromatic ?-? stacking inter-actions [shortest centroid-centroid distance = 3.8138?(11)?Å] are also observed.

| S-EPMC3884423 | biostudies-literature

rac-2-[2-(4-Fluoro-phen-yl)-2-oxo-1-phenyl-eth-yl]-4-methyl-3-oxo-N-phenyl-penta-namide.

Project description:The title compound, C(26)H(24)FNO(3), is a critical inter-mediate of a selective and competitive inhibitor of the enzyme 3-hy-droxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase. Inter-molecular N-H?O hydrogen bonding generates a chain along [give direction] that is the dominant inter-action in the crystal packing. Inter-molecular C-H?O inter-actions are also observed.

| S-EPMC3011484 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data